Lund-based RhoVac has had an intensive news flow so far this fall. BioStock invited CEO Anders Månsson to the studio to talk about the latest phase I/II follow-up results and the contracting of Investment Bank Stifel Nicolaus Europe, that will advise on the subsequent exit or partnership process.
Watch the full interview with RhoVac’s CEO Anders Månsson below.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.